Workflow
Pfizer Nears $7.3 Bln Acquisition Of Anti-Obesity Drugmaker Metsera - FT Reports
RTTNews·2025-09-22 09:08

Pfizer Inc. (PFE) is closing in on a 7.3billiondealtoacquireMetseraInc.(MTSR),aNewYork−basedbiotechfirmdevelopingnext−generationtreatmentsforobesity,accordingtotheFinancialTimes.Theproposedtransactionincludesacashofferof7.3 billion deal to acquire Metsera Inc. (MTSR), a New York-based biotech firm developing next-generation treatments for obesity, according to the Financial Times. The proposed transaction includes a cash offer of 47.50 per share, with an additional $22.50 per share contingent on performance milestones, a structure that could push the total value significantly higher.Metsera, founded in 2022, develops injectable and oral nutrient-stimulated hormone analog peptides to ...